| 2022 | | Biomarkers for diagnosing osteoarthritis | 김유선, 양시영 |
| 2022 | | Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor | 김장희, 박태준, 최용원 |
| 2020 | | Screening method for skin whitening agents using SDF1 promoter region | 강희영, 박태준 |
| 2020 | | CANCER CELL LINE FOR EVALUATING PARAPTOSIS, SCREENING METHOD FOR THE PARAPTOSIS INDUCERS AND SCREENING METHOD FOR SENSITIZERS OF PROTEASOME INHIBITORS USING THE SAME | 최경숙 |
| 2019 | | Increasing red muscle mass through TIS21 gene expression | 유민숙, 임인경 |
| 2018 | | Composition for regulating cutaneous pigmentation or skin whitening comprising SDF1 | 강희영, 김미선, 박태준 |
| 2018 | | Anticancer supplement composition comprising RIP3 activator, Method for screening anticancer supplement agents inducing RIP3 expression for enhancing sensitivity to anticancer agents and method for monitoring sensitivity to anticancer agents | 구기방, 김유선 |
| 2018 | | Composition for skin whitening comprising clusterin | 강희영, 김미선, 박태준 |
| 2018 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
| 2018 | | Composition comprising expression regulator for preventing or treating non-alcoholic fatty liver | 유민숙, 임인경, 최정아 |
| 2018 | | Recombinant BTG2 protein and production method thereof | 유민숙, 임인경 |
| 2017 | | Method for screening anticancer supplement agents inducing RIP3 expression for enhancing sensitivity to anticancer agents and method for monitoring sensitivity to anticancer agents | 구기방, 김유선 |
| 2017 | | MARCH5 K40/54R mutant protein maintaining MARCH5 activity and increasing protein stability | 김송희, 박용예, 유영석, 조혜성 |
| 2017 | | Anticancer supplement composition comprising RIP3 activator | 구기방, 김유선 |
| 2017 | | Composition for regulating cutaneous pigmentation derived from endothelial cells or secretory factors from endothelial cells and method for screening skin whitening agents | 강희영, 김미선, 박지윤, 박태준 |
| 2017 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction comprising NUPR1 and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
| 2017 | | Screening Method of therapeutic agents for cancer with mitochondrial dysfunction by regulation of Claudin-1 expression | 윤계순, 이영경 |
| 2017 | | Pharmaceutical composition for preventing or treating miRNA-34a related diseases comprising inducer or activator of TIS21 and screening method thereof | 유민숙, 임인경 |
| 2016 | | Anti-cancer supplement agent comprising flunarizine for glioma | 김인영, 최경숙 |
| 2016 | | Composition for preventing or treating tumor comprising proteasome inhibitor and dihydropyridine compound | 김인영, 최경숙 |
| 2016 | | Composition for treating pigmentary disorder or whitening skin through pleiotrophin modulation | 강희영, 박태준 |
| 2016 | | Pharmaceutical composition comprising RIP3-MLKL pathway blocker for preventing or treating of skin cell necrosis disease | 구기방, 김유선 |
| 2015 | | Method for screening modulator of RIG-I mediated immune response via stabilization of MARCH5 expression | 김송희, 박용예, 유영석, 조혜성 |
| 2015 | | Method for screening therapeutic agent of liver cancer by inducing HBx degradation via stabilization of MARCH5 expression | 박용예, 조혜성 |
| 2015 | | Anti-cancer supplement agent comprising polyether antibiotics for gliomas | 최경숙 |
| 2015 | | Pharmaceutical composition with antiviral activity comprising inhibitor of MARCH5 expression and screening method thereof | 박용예, 유영석, 조혜성 |
| 2015 | | Kit and method for diagnosis of cell senescence | 김유미, 변해옥, 우현구, 윤계순 |
| 2014 | | Pharmaceutical composition for treating or preventing cancer disease comprising proteasome inhibitor and loperamide | 김인영, 최경숙 |
| 2006 | | Micro Pump | 백운기 |
| - | | Method of obtaining information for identifying a tumor cell processed with epithelial-mesenchymal transition in a sample, method for identifying a tumor cell processed with epithelial-mesenchymal transition in a sample, method for diagnosing a subject suffering a tumor and composition or kit for identifying a tumor cell processed with epithelial-mesenchymal transition in a sample | 김유선 |
| - | | Composition and kit for cancer cell, and method for separating cancer cell using the same | 김유선 |
| - | | Biomarkers for diagnosing cancer and method for isolating cancer cell using the same | 김유선 |
| - | | A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator | 김유선 |
| - | | Biomarker composition for diagnosing cell senescence comprising UHRF1 and DNMT1 | 변해옥, 윤계순, 이영경 |
| - | | Pharmaceutical composition for preventing or treating bladder cancer comprising inducer or activator of BTG2 and screening method thereof | 임인경 |
| - | | Cosmetic Composition for Prevention of Skin Senescence | 김홍석, 유민숙, 임인경, 최옥란 |
| - | | Pharmaceutical composition of TIS21/BTG2 induser or activator for treatment or prevention of human diseases related with Diaphanous-related formins | 임인경, 최정아 |
| - | | Composition for preventing or treating osteoarthritis comprising Selumetinib | 김유선, 양시영 |
| - | | Composition for preventing or treating osteoarthritis comprising Neratinib | 김유선, 양시영 |
| - | | Composition containing B-cell lymphoma 2 inhibitor for anti-aging and whitening | 강희영, 박태준 |
| - | | Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor | 김장희, 박태준, 최용원 |
| - | | BIOMARKER FOR PREEDICTING FEMALE SPECIFIC LIVER CANCER MALIGNANCY AND USE THEREOF | 김유선 |
| - | | Patch-type skin moisture level sensor | 이진구 |
